treating [topp]
Metabolic syndrome [dsyn]
Acetyl-CoA Carboxylase [aapp, enzy]
Inhibition [menp]
Syndrome [dsyn]
Defined [cnce]
Clustering [resa]
cardiovascular risk factor [dsyn]
Obesity, Abdominal [dsyn]
Hyperinsulinaemia [dsyn]
Atherogenesis [patf]
Hypertension [dsyn]
Hypercoagulability [dsyn]
Together [qlco]
coronary heart disease [dsyn]
Type 2 Diabetes [dsyn]
Inhibition [menp]
Acetyl-CoA Carboxylase [aapp, enzy]
Inhibition [menp]
fatty acid synthesis [moft]
Stimulation [topp]
fatty acid oxidation [moft]
Affect [menp]
cardiovascular risk factor [dsyn]
Metabolic syndrome [dsyn]
ACC2 [gngm]
Knock-out Mice [mamm]
experimental animal [anim]
treated [topp]
Isozyme [aapp, enzy]
Acetyl-CoA Carboxylase [aapp, enzy]
inhibitors [chvf]
treating [topp]
Metabolic syndrome [dsyn]
Modality [idcn]
Variety [cnce]
Diverse [qlco]
Class [inpr]
Acetyl-CoA Carboxylase [aapp, enzy]
inhibitors [chvf]
Scientific [ocdi]
patent [inpr]
Literature [inpr]
Isozyme [aapp, enzy]
Acetyl-CoA Carboxylase [aapp, enzy]
inhibitors [chvf]
Optimal [qlco]
Therapeutic [topp]
Affecting [ftcn]
Metabolic [ftcn]
Full [qlco]
Isozyme [aapp, enzy]
inhibitors [chvf]
Identified [qlco]
Single [popg]
Isozyme [aapp, enzy]
Inhibition [menp]
Efficacy [qlco]
Acetyl-CoA Carboxylase [aapp, enzy]
Inhibitor [qlco]
Straightforward [qlco]
Heterogeneity [qlco]
absence [qnco]
Established [qlco]
Guidelines [inpr]
Approval [qlco]
End Point [qlco]
Agent [chvf]
simultaneously [tmco]
Affecting [ftcn]
Multiple [qnco]
Aspect [qnco]
Metabolic syndrome [dsyn]
Developmental [qlco]
challenges [hlca]
Initial [tmco]
Market [geoa]
Entry [inpr]
